Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$5.66 - $7.59 $10,612 - $14,231
-1,875 Reduced 33.03%
3,801 $24,000
Q1 2023

May 12, 2023

SELL
$7.31 - $11.18 $52,851 - $80,831
-7,230 Reduced 56.02%
5,676 $42,000
Q4 2022

Feb 14, 2023

BUY
$9.48 - $14.52 $30,971 - $47,436
3,267 Added 33.89%
12,906 $130,000
Q3 2022

Nov 14, 2022

BUY
$9.2 - $13.68 $80,500 - $119,700
8,750 Added 984.25%
9,639 $95,000
Q2 2022

Aug 15, 2022

BUY
$5.72 - $10.65 $1,224 - $2,279
214 Added 31.7%
889 $9,000
Q1 2022

May 13, 2022

BUY
$7.46 - $14.14 $850 - $1,611
114 Added 20.32%
675 $7,000
Q4 2021

Feb 11, 2022

SELL
$12.99 - $17.73 $389 - $531
-30 Reduced 5.08%
561 $8,000
Q3 2021

Feb 11, 2022

SELL
$14.85 - $21.34 $4,247 - $6,103
-286 Reduced 32.61%
591 $12,000
Q2 2021

Feb 11, 2022

BUY
$20.19 - $34.17 $8,156 - $13,804
404 Added 85.41%
877 $19,000
Q1 2021

Feb 08, 2022

BUY
$23.29 - $53.2 $11,016 - $25,163
473 New
473 $16,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $807M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.